Healthcare -
Biotechnology - NASDAQ - US
$ 2.95
-10.3 %
$ 2.15 B
Market Cap
-3.28
P/E
IBRX - TOTAL CURRENT ASSETS
Total Current Assets IBRX - ImmunityBio, Inc.
294 M
LAST VALUE
-6.21%
2 YEAR CAGR
27.07%
5 YEAR CAGR
76.93%
10 YEAR CAGR